NewAmsterdam Pharma Co N.V. (NAMS): SCHEDULE 13D/A filed Aug 20, 2025

Form type

SCHEDULE 13D/A

Filing date

Aug 20, 2025

Accession number

0001415889-25-022506

Filer

NewAmsterdam Pharma Co N.V. (CIK 1936258)